CUSIP: 29429X109
What is CUSIP 29429X109?
CUSIP 29429X109 identifies EPHY - EPIPHANY TECHNOLOGY ACQUISIT - COM CL A in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 29429X109:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$117,081,362 | 0 | |
| 2022 Q4 | 11,739,321 | $117,814,368 | -$230,057,156 | $10.00 | 47 |
| 2022 Q3 | 35,601,251 | $351,740,000 | +$17,418,283 | $9.88 | 86 |
| 2022 Q2 | 33,837,402 | $332,302,016 | +$2,666,968 | $9.82 | 94 |
| 2022 Q1 | 32,520,612 | $319,337,000 | +$1,720,409 | $9.82 | 90 |
| 2021 Q4 | 32,289,517 | $315,140,984 | +$9,929,250 | $9.76 | 81 |
| 2021 Q3 | 30,644,910 | $299,385,000 | +$26,531,660 | $9.77 | 79 |
| 2021 Q2 | 27,931,361 | $271,755,000 | +$82,499,191 | $9.73 | 76 |
| 2021 Q1 | 19,339,799 | $189,100,874 | +$188,936,874 | $9.79 | 62 |